Data derived from most recent annual or quarterly report
Market Cap	479.813 Million	Shares Outstanding	47.601 Million	Avg 30-day Volume	1.89 Million
P/E Ratio	0.0	Dividend Yield	0.0	EPS	-0.27
Price to Revenue	2.2094	Debt to Equity	-1.242	EBITDA	-47.621 Million
Price to Book Value	0.0	Operating Margin	-22.709699999999998	Enterprise Value	760.004 Million
Current Ratio	1.666	EPS Growth	-1	Quick Ratio	1.124
1 Yr BETA	0.9132	52-week High/Low	23.0 / 4.97	Profit Margin	-30.7247
Operating Cash Flow Growth	55.6249	Altman Z-Score	-11.1724	Free Cash Flow to Firm	-17.523 Million

Funds Holding RDUS (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RDUS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

4: filed on 2022-08-30 by BB BIOTECH AG

4: filed on 2022-08-15 by LISA SUSAN VISSERS

4: filed on 2022-08-15 by SANDERS MACHELLE

4: filed on 2022-08-15 by HUGHES OWEN

4: filed on 2022-08-15 by SHAH CHHAYA

4: filed on 2022-08-15 by FRIEDMAN CATHY

4: filed on 2022-08-15 by DERE WILLARD H

4: filed on 2022-08-15 by GARNIER JEAN PIERRE

4: filed on 2022-08-15 by JARRETT JENNIFER

4: filed on 2022-08-15 by VON ESCHENBACH ANDREW C.

Events (8k)

8-K: filed on 2022-08-15:

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-08-02:

Item 1.01: Entry into a Material Definitive Agreement

8-K: filed on 2022-07-28:

Item 5.07: Submission of Matters to a Vote of Security Holders

8-K: filed on 2022-06-27:

Item 8.01: Other Events

8-K: filed on 2022-06-23:

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-06-22:

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-06-08:

Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-06-06:

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-05-23:

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-05-05:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
BIOTECH TARGET N V BB BIOTECH AG	10% Owner	0	2022-08-15	2
GARNIER JEAN PIERRE	Director	0	2022-08-15	1
DERE WILLARD H	Director	0	2022-08-15	1
FRIEDMAN CATHY	Director	0	2022-08-15	1
VON ESCHENBACH ANDREW C.	Director	0	2022-08-15	1
HUGHES OWEN	Director	0	2022-08-15	1
MARTIN G. KELLY CEO AND PRESIDENT	Officer Director	0	2022-08-15	1
JARRETT JENNIFER	Director	0	2022-08-15	3
MURPHY SEAN	Director	0	2022-08-15	1
SANDERS MACHELLE	Director	0	2022-08-15	1
SHAH CHHAYA CHIEF BUSINESS OFFICER	Officer	0	2022-08-15	1
HOLTSCHLAG DANIELLE VICE PRESIDENT, SALES	Officer	0	2022-08-15	1
MESSERSMITH ELIZABETH SENIOR VICE PRESIDENT	Officer	0	2022-08-15	1
LISA SUSAN VISSERS	Director	0	2022-08-15	3
RUBRIC CAPITAL MANAGEMENT LP ROSEN DAVID EFRAIM	10% Owner	8,642,271	2022-08-10	2
CONLEY MARK WILLIAM VP, CHIEF FINANCIAL OFFICER	Officer	50,000	2022-03-15	0
HELWIG STEVEN PRINCIPAL FINANCIAL OFFICER	Officer	31,251	2022-01-14	0
RUBRIC CAPITAL MANAGEMENT LP	10% Owner	4,756,876	2021-12-08	2
CHOPAS JAMES GEORGE PRINCIPAL FINANCE ACCOUNTING	Officer	6,701	2021-03-05	0
GRAUSSO SAL CHIEF COMMERCIAL OFFICER	Officer	11,709	2021-02-25	0
DOLAN DAN VP OF FINANCE	Officer	0	2020-11-09	0
ROSENBERG ANTHONY	Director	12,401	2020-02-26	0
MORRIS CHARLES Q CHIEF MEDICAL OFFICER	Officer	33,744	2020-02-26	0
CARMONA JOSE CHIEF FINANCIAL OFFICER	Officer	46,708	2020-02-26	0
KELLY JOSEPH FRANCIS SR. VP OF SALES AND MARKETING	Officer	24,111	2020-02-26	0
GRAVES KURT	Director	11,000	2020-02-20	0
HOPFIELD JESSICA	Director	18,300	2020-02-20	0
HOEILAND JESPER PRESIDENT AND CEO	Officer Director	0	2020-02-20	0
BIOTECH GROWTH N V BB BIOTECH AG	10% Owner	6,881,685	2019-11-06	0
ROYCHOWDHURY DEBASISH	Director	5,500	2019-04-11	0
HATZIS-SCHOCH BRENT SR. VP, GENERAL COUNSEL	Officer	17,944	2019-02-22	0
HATTERSLEY GARY CHIEF SCIENTIFIC OFFICER	Officer	No longer subject to file	2018-12-31	0
FITZPATRICK LORRAINE A. CHIEF MEDICAL OFFICER	Officer	No longer subject to file	2018-12-31	0
WILLIAMS GREGORY C. CHIEF DEVELOPMENT OFFICER	Officer	0	2018-02-13	0
SNOW DAVID P. CHIEF COMMERCIAL OFFICER	Officer	No longer subject to file	2017-12-31	0
HARVEY BRIAN NICHOLAS SR. VP AND CFO	Officer	76,189	2017-04-25	0
GADICKE ANSBERT	Director	0	2017-02-17	0
AUERBACH ALAN H	Director	0	2017-02-17	0
WARD ROBERT PRESIDENT & CEO	Officer Director	0	2017-02-17	0
PURANDARE DINESH SVP, HEAD OF GLOBAL ONCOLOGY	Officer	0	2017-02-17	0
EVNIN LUKE	FORMER 10% STOCKHOLDER	No longer subject to file	2016-09-27	0
MPM BIOVENTURES III LLC HENNER DENNIS MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG MPM BIOVENTURES III PARALLEL FUND, L.P. MPM BIOVENTURES III GP L.P. MPM BIOVENTURES III L.P. MPM BIOVENTURES III-QP L.P. STEINMETZ MICHAEL	FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER	No longer subject to file	2016-09-27	0
MPM BIOVENTURES IV LLC SCOPA JAMES PAUL MPM BIOVENTURES IV GP LLC MPM BIO IV NVS STRATEGIC FUND LP KAILIAN VAUGHN M FOLEY TODD	FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER	No longer subject to file	2016-09-27	0
GALAKATOS NICHOLAS SIMON NICHOLAS J III WHEELER KURT	FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER	No longer subject to file	2016-09-27	0
WARD ROB PRESIDENT & CEO	Officer Director	0	2015-10-21	0
MUENCHBACH MARTIN	Director	0	2015-05-07	0
F2 BIOSCIENCE III, L.P. F2 BIOSCIENCE GP LTD. F2 CAPITAL LTD PRIESTLEY KATHERINE GLOBEWAYS HOLDINGS LTD	10% Owner	No longer subject to file	2015-01-16	0
F2 BIOSCIENCE IV L.P. F2 BIOSCIENCE IV GP LTD. F2 CAPITAL LTD PRIESTLEY KATHERINE F2 BIO VENTURES V L.P. F2 BIO VENTURES GP LTD. GLOBEWAYS HOLDINGS LTD	10% Owner	No longer subject to file	2015-01-16	0
JOVAN-EMBIRICOS MORANA	Director 10% Owner	0	2015-01-08	0
F2 BIOSCIENCE III, L.P. F2 BIOSCIENCE GP LTD. F2 CAPITAL LTD PRIESTLEY KATHERINE	10% Owner	1,167,997	2015-01-08	0
HARRIS ALAN G CHIEF MEDICAL OFFICER	Officer	0	2014-12-17	0
STONER ELIZABETH	Director	0	2014-12-17	0
F2 BIOSCIENCE IV L.P. F2 BIOSCIENCE IV GP LTD. F2 CAPITAL LTD PRIESTLEY KATHERINE F2 BIO VENTURES V L.P. F2 BIO VENTURES GP LTD. GLOBEWAYS HOLDINGS LTD F2 BIOSCIENCE VI L.P.	10% Owner	3,254,334	2014-06-11	0
F2 BIOSCIENCE VI L.P. F2 CAPITAL LTD PRIESTLEY KATHERINE GLOBEWAYS HOLDINGS LTD F2 BIOSCIENCE IV GP LTD.	10% Owner	587,500	2014-06-11	0
DURAND MARK CHIEF COMMERCIAL OFFICER	Officer	0	2014-06-05	0
MPM BIOVENTURES IV LLC SCOPA JAMES PAUL VANDER VORT JOHN MPM BIOVENTURES IV GP LLC MPM BIO IV NVS STRATEGIC FUND LP FOLEY TODD KAILIAN VAUGHN M	10% Owner	179,095	2013-04-23	0
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST	10% Owner	0	2011-12-14	0
MPM BIOVENTURES IV LLC MPM BIOVENTURES IV GP LLC MPM BIO IV NVS STRATEGIC FUND LP FOLEY TODD KAILIAN VAUGHN M SCOPA JAMES PAUL ST PETER STEVEN VANDER VORT JOHN	10% Owner	0	2011-12-14	0
FLEMING JONATHAN	Director	0	2011-12-14	0
HEALTHCARE VENTURES VII LP HEALTHCARE PARTNERS VII, L.P. CAVANAUGH JAMES H LAWLOR AUGUSTINE LITTLECHILD JOHN W MIRABELLI CHRISTOPHER WERNER HAROLD R	10% Owner	0	2011-11-18	0
LYTTLE CECIL RICHARD PRESIDENT AND CEO	Officer Director	0	2011-11-07	0
O'DEA LOUIS SR. VP, CHIEF MEDICAL OFFICER	Officer	0	2011-11-07	0
MPM BIOVENTURES IV LLC MPM BIOVENTURES IV GP LLC MPM BIO IV NVS STRATEGIC FUND LP DOMBKOWSKI ASHLEY L GREENE WILLIAM KAILIAN VAUGHN M SCOPA JAMES PAUL ST PETER STEVEN VANDER VORT JOHN	10% Owner	0	2011-05-17	0
IPSEN PHARMA SAS IPSEN, S.A.	10% Owner POSSIBLE 10% BENEFICIAL OWNER	0	2011-05-17	0
ST PETER STEVEN PRESIDENT	Officer Director	0	2008-06-15	0
VANDER VORT JOHN SECRETARY	Officer Director	0	2008-06-15	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available
RADIUS HEALTH INC RDUS	2022-08-15 22:15:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 21:45:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 21:15:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 20:45:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 20:15:03 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 19:45:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 19:15:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 18:45:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 18:15:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 17:45:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 17:15:03 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 16:45:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 16:15:04 UTC	1.4272	0.8928	3200000
RADIUS HEALTH INC RDUS	2022-08-15 15:45:04 UTC	1.4272	0.8928	100000
RADIUS HEALTH INC RDUS	2022-08-15 15:15:04 UTC	1.4272	0.8928	90000
RADIUS HEALTH INC RDUS	2022-08-15 14:45:04 UTC	1.4272	0.8928	90000
RADIUS HEALTH INC RDUS	2022-08-15 14:15:03 UTC	1.4272	0.8928	90000
RADIUS HEALTH INC RDUS	2022-08-15 13:45:04 UTC	1.4607	0.8593	90000
RADIUS HEALTH INC RDUS	2022-08-15 13:15:04 UTC	1.4607	0.8593	90000
RADIUS HEALTH INC RDUS	2022-08-15 12:45:04 UTC	1.4607	0.8593	100000

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund	RDUS	-1200.0 shares, $-14892.0	2021-09-30	N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio	RDUS	-19600.0 shares, $-243236.0	2021-09-30	N-PORT

Radius Health Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Radius Health Inc (RDUS)

Funds Holding RDUS (via 13F filings)

Filter by:

Mutual Funds Holding RDUS

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

No recent transactions

* To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page*

Elevate your investments

Radius Health Inc (RDUS)

Funds Holding RDUS (via 13F filings)

Filter by:

Mutual Funds Holding RDUS

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments

* To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page*